\begin{table}[!h] \centering \\ \caption{Knowledge transfer: Management indicators frequency} \\ \begin{adjustbox}{width=\columnwidth,center} \\ \begin{tabular}{l*{8}{c}} \hline\hline
                    &\multicolumn{1}{c}{(1)}         \\
                    &frequency of examining financial performance         \\
\hline \\ \multicolumn{7}{c}{\textbf{Panel A: Intention-to-treat (ITT)}} \\\\[-1ex]
Treatment           &       0.066         \\
                    &     (0.150)         \\
                    &       0.661         \\
                    &                     \\
                    &  -0.23,0.37         \\
Y0 man\_fin\_per\_fre  &       0.000         \\
                    &         (.)         \\
                    &           .         \\
                    &                     \\
                    &   0.00,0.00         \\
\hline \\ \multicolumn{7}{c}{\textbf{Panel B: Treatment Effect on the Treated (TOT)}} \\\\[-1ex]
Consortium participant&       0.100         \\
                    &     (0.193)         \\
                    &       0.606         \\
                    &                     \\
                    &  -0.28,0.48         \\
Y0 man\_fin\_per\_fre  &       0.000         \\
                    &         (.)         \\
                    &           .         \\
                    &                     \\
                    &   0.00,0.00         \\
\hline
Control group mean  &                     \\
Control group SD    &                     \\
Observations        &         118         \\
strata\_final controls&                     \\
Y0 controls         &         Yes         \\
\hline\hline\hline \\ \multicolumn{7}{@{}p{\textwidth}@{}}{ \footnotesize \parbox{\linewidth}{% Notes: Each specification includes controls for randomization strata\_final, baseline outcome, and a missing baseline dummy. All variables are winsorized at the 99th percentile and ihs-transformed. The units for ihs-transformation are chosen based on the highest R-square, ten thousands for all variables, as described in Aihounton and Henningsen (2020). Panel A reports ANCOVA estimates as defined in Mckenzie and Bruhn (2011). Panel B documents IV estimates, instrumenting take-up with treatment assignment. Clustered standard errors by firms in parentheses. \sym{***} \(p<0.01\), \sym{**} \(p<0.05\), \sym{*} \(p<0.1\) denote the significance level. P-values and adjusted p-values for multiple hypotheses testing using the Romano-Wolf correction procedure (Clarke et al., 2020) with 999 bootstrap replications are reported below the standard errors.% \\ }} \\ \end{tabular} \\ \end{adjustbox} \\ \end{table}
\hline \\ \multicolumn{7}{c}{\textbf{Panel B: Treatment Effect on the Treated (TOT)}} \\\\[-1ex]
Consortium participant&       0.092\sym{*}  \\
                    &     (0.055)         \\
                    &       0.091         \\
                    &                     \\
                    &  -0.01,0.20         \\
\hline
Control group mean  &                     \\
Control group SD    &                     \\
Observations        &         118         \\
strata\_final controls&                     \\
Y0 controls         &         Yes         \\
\hline\hline\hline \\ \multicolumn{7}{@{}p{\textwidth}@{}}{ \footnotesize \parbox{\linewidth}{% Notes: Each specification includes controls for randomization strata. All variables are winsorized at the 99th percentile and ihs-transformed. The units for ihs-transformation are chosen based on the highest R-square, ten thousands for all variables, as described in Aihounton and Henningsen (2020). Panel A reports ANCOVA estimates as defined in Mckenzie and Bruhn (2011). Panel B documents IV estimates, instrumenting take-up with treatment assignment. Clustered standard errors by firms in parentheses. \sym{***} \(p<0.01\), \sym{**} \(p<0.05\), \sym{*} \(p<0.1\) denote the significance level. P-values and adjusted p-values for multiple hypotheses testing using the Romano-Wolf correction procedure (Clarke et al., 2020) with 999 bootstrap replications are reported below the standard errors.% \\ }} \\ \end{tabular} \\ \end{adjustbox} \\ \end{table}
\hline \\ \multicolumn{7}{c}{\textbf{Panel B: Treatment Effect on the Treated (TOT)}} \\\\[-1ex]
Consortium participant&       0.092\sym{*}  \\
                    &     (0.055)         \\
                    &       0.091         \\
                    &                     \\
                    &  -0.01,0.20         \\
\hline
Control group mean  &                     \\
Control group SD    &                     \\
Observations        &         118         \\
strata\_final controls&                     \\
Y0 controls         &         Yes         \\
\hline\hline\hline \\ \multicolumn{7}{@{}p{\textwidth}@{}}{ \footnotesize \parbox{\linewidth}{% Notes: Each specification includes controls for randomization strata. All variables are winsorized at the 99th percentile and ihs-transformed. The units for ihs-transformation are chosen based on the highest R-square, ten thousands for all variables, as described in Aihounton and Henningsen (2020). Panel A reports ANCOVA estimates as defined in Mckenzie and Bruhn (2011). Panel B documents IV estimates, instrumenting take-up with treatment assignment. Clustered standard errors by firms in parentheses. \sym{***} \(p<0.01\), \sym{**} \(p<0.05\), \sym{*} \(p<0.1\) denote the significance level. P-values and adjusted p-values for multiple hypotheses testing using the Romano-Wolf correction procedure (Clarke et al., 2020) with 999 bootstrap replications are reported below the standard errors.% \\ }} \\ \end{tabular} \\ \end{adjustbox} \\ \end{table}
